According to the study, technologies that received scientific advice took a median of 312 days to progress from marketing ...

These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

In the talks both ourselves and NHS England continued to offer as much flexibility as possible, but despite the intervention of Secretary of State for Health Wes Streeting, the companies did not put ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found. The guideline makes new recommendations and updates ...

Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease Interventional procedure consultation Interventional procedures guidance 12 December 2024 Zilucoplan for treating ...

03 October 2024 This update will cover: Ovarian Function Suppression, Chemotherapy for Advanced Breast Cancer and Biological Therapy for Advanced Breast Cancer For further information on the guideline ...

Colleagues in our Science Policy and Research Programme discuss their international research, paving the way for next generation health technology assessment. Dr Dalia Dawoud, associate director of ...

Neupulse is a wearable wrist-worn device linked to a mobile phone app, used to treat those over the age of 12. The device delivers low-intensity electrical pulses to the median nerve to reduce tic ...

There is a simple discount patient access scheme for crovalimab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...